ID
37721
Beschreibung
Study ID: 104864/517 Clinical Study ID: 104864/517 Study Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00158886 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Topotecan + Radiation therapy Trade Name: N/A Study Indication: Rectal Cancer, Carcinoma, Renal Cell
Stichworte
Versionen (1)
- 20.08.19 20.08.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
20. August 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Oral Topotecan as Radiosensitizing Agent in Patients with Rectal Cancer; NCT00158886
Study Conclusion
- StudyEvent: ODM
Beschreibung
Study Conclusion
Alias
- UMLS CUI-1
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
- UMLS CUI-2
- C1707478 (Conclusion)
Beschreibung
Clinical Trials, Complete
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
- UMLS CUI [1,2]
- C0205197 (Complete)
- SNOMED
- 255594003
- LOINC
- LA13937-0
Beschreibung
Clinical Trials, Withdraw, Reason and justification
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
- UMLS CUI [1,2]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,3]
- C0566251 (Reason and justification)
- SNOMED
- 288830005
Beschreibung
Clinical Trials, Withdraw, Reason and justification
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
- UMLS CUI [1,2]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,3]
- C0566251 (Reason and justification)
- SNOMED
- 288830005
Beschreibung
Clinical Trials, Withdraw, Reason and justification, Comment
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
- UMLS CUI [1,2]
- C2349954 (Withdraw (activity))
- UMLS CUI [1,3]
- C0566251 (Reason and justification)
- SNOMED
- 288830005
- UMLS CUI [1,4]
- C0947611 (Comment)
- LOINC
- LP72293-1
Beschreibung
Clinical Trials, Evaluation, Final, Date in time
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
- UMLS CUI [1,2]
- C0220825 (Evaluation)
- LOINC
- LP36377-7
- UMLS CUI [1,3]
- C3853528 (Final)
- LOINC
- LA16388-3
- UMLS CUI [1,4]
- C0011008 (Date in time)
- SNOMED
- 410671006
Beschreibung
Investigator's Signature
Alias
- UMLS CUI-1
- C2346576 (Investigator Signature)
Beschreibung
Investigator Signature
Datentyp
text
Alias
- UMLS CUI [1]
- C2346576 (Investigator Signature)
Beschreibung
Investigator Signature, Date in time
Datentyp
date
Alias
- UMLS CUI [1,1]
- C2346576 (Investigator Signature)
- UMLS CUI [1,2]
- C0011008 (Date in time)
- SNOMED
- 410671006
Ähnliche Modelle
Study Conclusion
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C2349954 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C2349954 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0947611 (UMLS CUI [1,4])
C0220825 (UMLS CUI [1,2])
C3853528 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0011008 (UMLS CUI [1,2])
Keine Kommentare